Aurinia Pharmaceuticals Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.12M0.42M0.46M0.32M50.12M45.60M134.03M175.51M235.13M
Cost of Revenue 1.09M5.66M14.15M28.25M
Gross Profit 0.12M0.42M0.46M0.32M50.12M44.51M128.37M161.37M206.88M
Operating items
Amortization - Intangibles 1.30M1.14M1.30M2.10M
Depreciation & Amortization - Total 0.02M0.16M
Research & Development 14.53M33.93M41.40M52.90M50.33M51.14M44.99M49.64M20.79M
Selling, General & Administrative 6.97M12.10M13.69M22.34M97.27M173.54M196.37M195.04M172.03M
Restructuring Costs 0.27M-0.15M-0.12M
Other Operating Expenses -0.67M-14.92M-6.81M-0.57M1.52M-8.38M4.35M
Operating Expenses 0.27M-0.15M21.39M46.03M55.70M91.26M154.41M226.34M245.50M267.20M239.82M
Operating Income -55.24M-90.94M-104.29M-180.74M-111.47M-91.69M-4.69M
EBIT -70.79M-55.24M-90.94M-104.29M-180.74M-111.47M-91.69M-4.69M
Non-operating items
Non Operating Investment Income -0.08M
Interest & Investment Income 2.23M2.70M1.52M0.53M5.12M17.00M16.97M
Other Non Operating Income 1.73M-23.92M-9.95M-41.12M
Non Operating Income -0.04M
Net income details
EBT -70.79M-53.01M-88.24M-102.77M-180.21M-106.35M-77.47M7.45M
Tax Provisions 0.14M-0.09M0.76M1.83M0.60M1.70M
Profit After Tax -23.30M-70.79M-53.08M-88.39M-102.68M-180.97M-108.18M-78.02M5.75M
Income from Continuing Operations -70.79M-53.01M-88.39M-102.68M-180.97M-108.18M-78.07M5.75M
Consolidated Net Income -70.79M-53.01M-88.39M-102.68M-180.97M-108.18M-78.07M5.75M
Income towards Parent Company -70.79M-53.01M-88.39M-102.68M-180.97M-108.18M-78.07M5.75M
Net Income towards Common Stockholders -70.79M-53.01M-88.39M-102.68M-180.97M-108.18M-78.07M5.75M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 31.37M31.37M31.82M38.79M83.97M84.05M94.28M126.45M141.65M142.11M143.61M143.18M
Shares Outstanding (Diluted Average) 118.47M129.37M141.91M143.24M146.19M
EBITDA -20.03M-23.30M-70.87M-64.12M-88.39M-102.68M-181.01M-108.39M-77.69M5.83M
Tax Rate 0.09%22.82%